CC BY-NC-ND 4.0 · Methods Inf Med 2023; 62(03/04): 130-139
DOI: 10.1055/s-0043-1768711
Original Article

From Paper Files to Web-Based Application for Data-Driven Monitoring of HIV Programs: Nigeria's Journey to a National Data Repository for Decision-Making and Patient Care

Ibrahim Dalhatu*
1   United States Centers for Disease Control and Prevention, Abuja, Nigeria
,
Chinedu Aniekwe*
1   United States Centers for Disease Control and Prevention, Abuja, Nigeria
,
Adebobola Bashorun
2   Federal Ministry of Health, Abuja, Nigeria
,
Alhassan Abdulkadir
3   Center for International Health, Education and Biosecurity, University of Maryland, Baltimore, Abuja, Nigeria
,
Emilio Dirlikov
4   United States Centers for Disease Control and Prevention, Atlanta, Georgia, United States
,
Stephen Ohakanu
5   Center for International Health, Education and Biosecurity, Institute of Human Virology, University of Maryland School of Medicine, University of Maryland, Baltimore, Maryland, United States
,
Oluwasanmi Adedokun
3   Center for International Health, Education and Biosecurity, University of Maryland, Baltimore, Abuja, Nigeria
,
Ademola Oladipo
1   United States Centers for Disease Control and Prevention, Abuja, Nigeria
,
Ibrahim Jahun
1   United States Centers for Disease Control and Prevention, Abuja, Nigeria
,
Lisa Murie
4   United States Centers for Disease Control and Prevention, Atlanta, Georgia, United States
,
Steven Yoon
4   United States Centers for Disease Control and Prevention, Atlanta, Georgia, United States
,
Mubarak G. Abdu-Aguye
3   Center for International Health, Education and Biosecurity, University of Maryland, Baltimore, Abuja, Nigeria
,
Ahmed Sylvanus
3   Center for International Health, Education and Biosecurity, University of Maryland, Baltimore, Abuja, Nigeria
,
Samuel Indyer
3   Center for International Health, Education and Biosecurity, University of Maryland, Baltimore, Abuja, Nigeria
,
Isah Abbas
1   United States Centers for Disease Control and Prevention, Abuja, Nigeria
,
Mustapha Bello
1   United States Centers for Disease Control and Prevention, Abuja, Nigeria
,
Nannim Nalda
1   United States Centers for Disease Control and Prevention, Abuja, Nigeria
,
Matthias Alagi
1   United States Centers for Disease Control and Prevention, Abuja, Nigeria
,
Solomon Odafe
1   United States Centers for Disease Control and Prevention, Abuja, Nigeria
,
Sylvia Adebajo
3   Center for International Health, Education and Biosecurity, University of Maryland, Baltimore, Abuja, Nigeria
,
Otse Ogorry
6   PEPFAR Coordination Office, Abuja, Nigeria
,
Murphy Akpu
6   PEPFAR Coordination Office, Abuja, Nigeria
,
Ifeanyi Okoye
7   United States Department of Defense Walter Reed Program, Abuja, Nigeria
,
Kunle Kakanfo
8   United States Agency for International Development (USAID), Abuja, Nigeria
,
Amobi Andrew Onovo
8   United States Agency for International Development (USAID), Abuja, Nigeria
,
Gregory Ashefor
9   Division of Global HIV and TB, US Centers for Disease Control and Prevention, Abuja, Federal Capital Territory, Nigeria
,
Charles Nzelu
2   Federal Ministry of Health, Abuja, Nigeria
,
Akudo Ikpeazu
2   Federal Ministry of Health, Abuja, Nigeria
,
Gambo Aliyu
9   Division of Global HIV and TB, US Centers for Disease Control and Prevention, Abuja, Federal Capital Territory, Nigeria
,
Tedd Ellerbrock
4   United States Centers for Disease Control and Prevention, Atlanta, Georgia, United States
,
Mary Boyd
1   United States Centers for Disease Control and Prevention, Abuja, Nigeria
,
Kristen A. Stafford*
5   Center for International Health, Education and Biosecurity, Institute of Human Virology, University of Maryland School of Medicine, University of Maryland, Baltimore, Maryland, United States
,
Mahesh Swaminathan*
1   United States Centers for Disease Control and Prevention, Abuja, Nigeria
› Author Affiliations
Funding This project has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of NU2GGH001976.

Abstract

Background Timely and reliable data are crucial for clinical, epidemiologic, and program management decision making. Electronic health information systems provide platforms for managing large longitudinal patient records. Nigeria implemented the National Data Repository (NDR) to create a central data warehouse of all people living with human immunodeficiency virus (PLHIV) while providing useful functionalities to aid decision making at different levels of program implementation.

Objective We describe the Nigeria NDR and its development process, including its use for surveillance, research, and national HIV program monitoring toward achieving HIV epidemic control.

Methods Stakeholder engagement meetings were held in 2013 to gather information on data elements and vocabulary standards for reporting patient-level information, technical infrastructure, human capacity requirements, and information flow. Findings from these meetings guided the development of the NDR. An implementation guide provided common terminologies and data reporting structures for data exchange between the NDR and the electronic medical record (EMR) systems. Data from the EMR were encoded in extensible markup language and sent to the NDR over secure hypertext transfer protocol after going through a series of validation processes.

Results By June 30, 2021, the NDR had up-to-date records of 1,477,064 (94.4%) patients receiving HIV treatment across 1,985 health facilities, of which 1,266,512 (85.7%) patient records had fingerprint template data to support unique patient identification and record linkage to prevent registration of the same patient under different identities. Data from the NDR was used to support HIV program monitoring, case-based surveillance and production of products like the monthly lists of patients who have treatment interruptions and dashboards for monitoring HIV test and start.

Conclusion The NDR enabled the availability of reliable and timely data for surveillance, research, and HIV program monitoring to guide program improvements to accelerate progress toward epidemic control.

Ethical Approval Statement

This project was reviewed in accordance with CDC human research protection procedures and was determined to be nonresearch.


Authors' Contribution

The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the funding agencies.


* These authors contributed equally to this work.




Publication History

Received: 09 June 2022

Accepted: 13 January 2023

Article published online:
29 May 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Stuttgart · New York